Literature DB >> 11407725

Clinical characteristics of patients with constrictive pericarditis after coronary bypass surgery.

K Matsuyama1, M Matsumoto, T Sugita, J Nishizawa, T Yoshioka, Y Tokuda, Y Ueda.   

Abstract

Constrictive pericarditis (CP) is an unusual sequela of cardiac surgery, so the present study evaluated the clinical characteristics of patients with CP after coronary artery bypass grafting (CABG). Four hundred and sixty-three patients who underwent isolated CABG between January 1989 and March 1999 were examined retrospectively. The first choice of treatment for postoperative pericardial effusion was non-steroid anti-inflammatory agents, and an increased dose of diuretics. The second treatment choice was corticosteroids or pericardial drainage. When CP was suspected during the follow-up period (mean, 54+/-31 months), cardiac catheterization was carried out to establish the diagnosis. Of the 463 patients undergoing CABG, there were 11 (2.4%) who developed CP after surgery. The median time to the onset of symptoms after CABG was 4 weeks (range, 3-96 weeks). On univariate and multivariate analysis, normal left ventricular ejection fraction, warfarin administration, and early postoperative pericardial effusion were significantly associated with a greater potential of postoperative CP. The effusion was bloody in all cases of pericardial drainage despite warfarin therapy. Not draining the postoperative effusive pericardial effusion was a risk factor for the development of CP. Pericardial drainage for patients with significant effusion after CABG is important for the prevention of subsequent CP, especially in those patients being treated with warfarin or with normal left ventricular function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11407725     DOI: 10.1253/jcj.65.480

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  8 in total

Review 1.  Constrictive pericarditis--a curable diastolic heart failure.

Authors:  Faisal F Syed; Hartzell V Schaff; Jae K Oh
Journal:  Nat Rev Cardiol       Date:  2014-07-29       Impact factor: 32.419

2.  Transient constrictive pericarditis after coronary bypass surgery.

Authors:  Jae-Bum Kim; Nam-Hee Park; Sae-Young Choi; Hyungseop Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2011-02-12

3.  Incidence, Predictors, and Clinical Outcomes of Postoperative Cardiac Tamponade in Patients Undergoing Heart Valve Surgery.

Authors:  Seng Chan You; Chi Young Shim; Geu-Ru Hong; Darae Kim; In Jeong Cho; Sak Lee; Hyuck-Jae Chang; Jong-Won Ha; Byung-Chul Chang; Namsik Chung
Journal:  PLoS One       Date:  2016-11-17       Impact factor: 3.240

Review 4.  Established and novel pathophysiological mechanisms of pericardial injury and constrictive pericarditis.

Authors:  Vinasha Ramasamy; Bongani M Mayosi; Edward D Sturrock; Mpiko Ntsekhe
Journal:  World J Cardiol       Date:  2018-09-26

5.  Frequent Constriction-Like Echocardiographic Findings in Elite Athletes Following Mild COVID-19: A Propensity Score-Matched Analysis.

Authors:  Bálint Károly Lakatos; Márton Tokodi; Alexandra Fábián; Zsuzsanna Ladányi; Hajnalka Vágó; Liliána Szabó; Nóra Sydó; Emese Csulak; Orsolya Kiss; Máté Babity; Anna Réka Kiss; Zsófia Gregor; Andrea Szűcs; Béla Merkely; Attila Kovács
Journal:  Front Cardiovasc Med       Date:  2022-01-05

6.  Acute Pericarditis after Percutaneous Coronary Intervention: A Case Report.

Authors:  Greta Rodevič; Povilas Budrys; Giedrius Davidavičius
Journal:  Medicina (Kaunas)       Date:  2021-05-13       Impact factor: 2.430

7.  Effect of postoperative constrictive physiology on early outcomes after off-pump coronary artery bypass grafting.

Authors:  Jung-Hwan Kim; Yoo-Hwa Hwang; Young-Nam Youn; Kyung-Jong Yoo
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-02-06

8.  Pericardial hematoma after cardiac surgery: An unexpected cause of constrictive pericarditis.

Authors:  Nil Özyüncü; Buse Güleç; Kerim Esenboğa; Sibel Turhan
Journal:  Anatol J Cardiol       Date:  2020-11       Impact factor: 1.596

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.